参考文献/References:
[1] Lin X,Swedlund B,Ton MN,et al. Mesp1 controls the chromatin and enhancer landscapes essential for spatiotemporal patterning of early cardiovascular progenitors[J]. Nat Cell Biol,2022,24(7):1114-1128.
[2] Shewale B,Dubois N. Of form and function:Early cardiac morphogenesis across classical and emerging model systems[J]. Semin Cell Dev Biol,2021,118:107-118.
[3] Zhou X,Li Z,Wang Z,et al. Syncytium calcium signaling and macrophage function in the heart[J]. Cell Biosci,2018,8:24.
[4] Materna SC,Sinha T,Barnes RM,et al. Cardiovascular development and survival require Mef2c function in the myocardial but not the endothelial lineage[J]. Dev Biol,2019,445(2):170-177.
[5] Santos-Ledo A,Washer S,Dhanaseelan T,et al. Alternative splicing of jnk1a in zebrafish determines first heart field ventricular cardiomyocyte numbers through modulation of hand2 expression[J]. PLoS Genet,2020,16(5):e1008782.
[6] V?lim?ki MJ,Leigh RS,Kinnunen SM,et al. GATA-targeted compounds modulate cardiac subtype cell differentiation in dual reporter stem cell line[J]. Stem Cell Res Ther,2021,12(1):190.
[7] Balsalobre A,Drouin J. Pioneer factors as master regulators of the epigenome and cell fate[J]. Nat Rev Mol Cell Biol,2022,23(7):449-464.
[8] Gao R,Liang X,Cheedipudi S,et al. Pioneering function of Isl1 in the epigenetic control of cardiomyocyte cell fate[J]. Cell Res,2019,29(6):486-501.
[9] Jia G,Preussner J,Chen X,et al. Single cell rna-seq and atac-seq analysis of cardiac progenitor cell transition states and lineage settlement[J]. Nat Commun,2018,9(1):4877.
[10] Steimle JD,Moskowitz IP. TBX5:a key regulator of heart development[J]. Curr Top Dev Biol,2017,122:195-221.
[11] Takeuchi JK,Bruneau BG. Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors[J]. Nature,2009,459(7247):708-711.
[12] Drakhlis L,Biswanath S,Farr CM,et al. Human heart-forming organoids recapitulate early heart and foregut development[J]. Nat Biotechnol,2021,39(6):737-746.
[13] Swedlund B,Lescroart F. Cardiopharyngeal progenitor specification:multiple roads to the heart and head muscles[J]. Cold Spring Harb Perspect Biol,2020,12(8):a036731.
[14] Ajima R,Sakakibara Y,Sakurai-Yamatani N,et al. Formal proof of the requirement of MESP1 and MESP2 in mesoderm specification and their transcriptional control via specific enhancers in mice[J]. Development,2021,148(20):dev194613.
[15] Wang H,Yang Y,Liu J,et al. Direct cell reprogramming:approaches,mechanisms and progress[J]. Nat Rev Mol Cell Biol,2021,22(6):410-424.
[16] Garry GA,Bassel-Duby R,Olson EN. Direct reprogramming as a route to cardiac repair[J]. Semin Cell Dev Biol,2022,122:3-13.
[17] Xie Y,Liu J,Qian L. Direct cardiac reprogramming comes of age:Recent advance and remaining challenges[J]. Semin Cell Dev Biol,2022,122:37-43.
[18] Isomi M,Sadahiro T,Yamakawa H,et al. Overexpression of gata4,mef2c,and tbx5 generates induced cardiomyocytes via direct reprogramming and rare fusion in the heart[J]. Circulation,2021,143(21):2123-2125.
[19] Tang Y,Aryal S,Geng X,et al. Tbx20 improves contractility and mitochondrial function during direct human cardiac reprogramming[J]. Circulation,2022,146(20):1518-1536.
[20] Wang L,Liu Z,Yin C,et al. Stoichiometry of Gata4,Mef2c,and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming[J]. Circ Res,2015,116(2):237-244.
[21] Stone NR,Gifford CA,Thomas R,et al. Context-specific transcription factor functions regulate epigenomic and transcriptional dynamics during cardiac reprogramming[J]. Cell Stem Cell,2019,25(1):87-102.e9.
[22] Paoletti C,Divieto C,Tarricone G,et al. Microrna-mediated direct reprogramming of human adult fibroblasts toward cardiac phenotype[J]. Front Bioeng Biotechnol,2020,8:529.
[23] Zhong Z,Hou J,Zhang Q,et al. Circulating microRNA expression profiling and bioinformatics analysis of dysregulated microRNAs of patients with coronary artery disease[J]. Medicine (Baltimore),2018,97(27):e11428.
[24] Baksh SS,Hodgkinson CP. Conservation of miR combo based direct cardiac reprogramming[J]. Biochem Biophys Rep,2022,31:101310.
[25] Garbutt TA,Zhou Y,Keepers B,et al. An optimized protocol for human direct cardiac reprogramming[J]. STAR Protoc,2020,1(1):100010.
[26] Jiang L,Liang J,Huang W,et al. Strategies and challenges to improve cellular programming-based approaches for heart regeneration therapy[J]. Int J Mol Sci,2020,21(20):7662.
[27] Wang H,Cao N,Spencer CI,et al. Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor,Oct4[J]. Cell Rep,2014,6(5):951-960.
[28] Werner JH,Rosenberg Jh,UM JY,et al. Molecular discoveries and treatment strategies by direct reprogramming in cardiac regeneration[J]. Transl Res,2019,203:73-87.
[29] Yamakawa H,Ieda M. Cardiac regeneration by direct reprogramming in this decade and beyond[J]. Inflamm Regen,2021,41(1):20.
[30] Abad M,Hashimoto H,Zhou H,et al. Notch inhibition enhances cardiac reprogramming by increasing mef2c transcriptional activity[J]. Stem Cell Reports,2017,8(3):548-560.
[31] Bektik E,Sun Y,Dennis AT,et al. Inhibition of creb-cbp signaling improves fibroblast plasticity for direct cardiac reprogramming[J]. Cells,2021,10(7):1572.
[32] Kurotsu S,Sadahiro T,Fujita R,et al. Soft matrix promotes cardiac reprogramming via inhibition of yap/taz and suppression of fibroblast signatures[J]. Stem Cell Reports,2020,15(3):612-628.
[33] Herum KM,Choppe J,Kumar A,et al. Mechanical regulation of cardiac fibroblast profibrotic phenotypes[J]. Mol Biol Cell,2017,28(14):1871-1882.
[34] Song SY,Yoo J,Go S,et al. Cardiac-mimetic cell-culture system for direct cardiac reprogramming[J]. Theranostics,2019,9(23):6734-6744.
[35] Li Y,Dal-Pra S,Mirotsou M,et al. Tissue-engineered 3-dimensional (3D) microenvironment enhances the direct reprogramming of fibroblasts into cardiomyocytes by microRNAs[J]. Sci Rep,2016,6:38815.
[36] Paoletti C,Marcello E,Melis ML,et al. Cardiac tissue-like 3d microenvironment enhances route towards human fibroblast direct reprogramming into induced cardiomyocytes by micrornas[J]. Cells,2022,11(5):800.
[37] Kim H,Song BW,Park SJ,et al. Ultraefficient extracellular vesicle-guided direct reprogramming of fibroblasts into functional cardiomyocytes[J]. Sci Adv,2022,8(8):eabj6621.
[38] Chang Y,Lee E,Kim J,et al. Efficient in vivo direct conversion of fibroblasts into cardiomyocytes using a nanoparticle-based gene carrier[J]. Biomaterials,2019,192:500-509.
[39] Wang Q,Song Y,Chen J,et al. Direct in vivo reprogramming with non-viral sequential targeting nanoparticles promotes cardiac regeneration[J]. Biomaterials,2021,276:121028.
[40] Vaseghi H,Liu J,Qian L. Molecular barriers to direct cardiac reprogramming[J]. Protein Cell,2017,8(10):724-734.
[41] Chen Y,Yang Z,Zhao ZA,et al. Direct reprogramming of fibroblasts into cardiomyocytes[J]. Stem Cell Res Ther,2017,8(1):118.
[42] Sauls K,Greco TM,Wang L,et al. Initiating events in direct cardiomyocyte reprogramming[J]. Cell Rep,2018,22(7):1913-1922.